Yajnik C S, Shelgikar K M, Sahasrabudhe R A, Naik S S, Pai V R, Alberti K G, Hockaday T D, Katrak A, Dandona P
Wellcome Diabetes Study, King Edward Memorial Hospital, Pune, India.
Diabetologia. 1990 Jul;33(7):417-21. doi: 10.1007/BF00404091.
Exocrine pancreatic marker (immunoreactive-trypsin) and endocrine Beta-cell function (plasma insulin and C-peptide during an oral glucose tolerance test) were studied in 40 subjects with tropical-calcific-pancreatitis [seven non-diabetic, seven with impaired-glucose-tolerance and 26 diabetic (fibro-calculous-pancreatic-diabetes)]. In non-diabetic and impaired-glucose-tolerance subjects there was evidence of active pancreatitis in some and exocrine function was partially preserved. Fibro-calculous-pancreatic-diabetic subjects showed severely diminished exocrine pancreatic function; none showed 'pancreatitic' elevation of immunoreactive-trypsin. Beta-cell function was preserved in non-diabetic and impaired-glucose-tolerance subjects; diabetic subjects showed variable Beta-cell function but it was severely diminished in more than 75%. Immunoreactive-trypsin and C-peptide were directly correlated (rs = 0.55, p less than 0.01). This cross sectional study demonstrates, for the first time, that the Beta-cell loss in tropical-calcific-pancreatitis is related to the exocrine loss. It suggests that diabetes in tropical-calcific-pancreatitis is either secondary to pancreatitis or that a common factor(s) acts simultaneously on both components.
对40例热带钙化性胰腺炎患者[7例非糖尿病患者、7例糖耐量受损患者和26例糖尿病患者(纤维钙化性胰腺糖尿病)]进行了外分泌胰腺标志物(免疫反应性胰蛋白酶)和内分泌β细胞功能(口服葡萄糖耐量试验期间的血浆胰岛素和C肽)研究。在非糖尿病和糖耐量受损患者中,部分患者存在活动性胰腺炎的证据,外分泌功能部分保留。纤维钙化性胰腺糖尿病患者的外分泌胰腺功能严重减退;无一例显示免疫反应性胰蛋白酶出现“胰腺炎性”升高。非糖尿病和糖耐量受损患者的β细胞功能得以保留;糖尿病患者的β细胞功能各异,但超过75%的患者β细胞功能严重减退。免疫反应性胰蛋白酶和C肽呈直接相关(rs = 0.55,p<0.01)。这项横断面研究首次表明,热带钙化性胰腺炎中的β细胞丢失与外分泌功能丧失有关。这表明热带钙化性胰腺炎中的糖尿病要么继发于胰腺炎,要么存在一个共同因素同时作用于这两个组成部分。